Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
2.
Mediastinum ; 6: 31, 2022.
Article in English | MEDLINE | ID: mdl-36582980

ABSTRACT

Background and Objective: Whether and when surgical intervention is indicated for mediastinal cysts is a matter of some debate. While most mediastinal cysts are found incidentally, the anatomic location, clinical presentation, and symptoms, as well as the potential for malignancy, are important considerations that inform decisions related to whether to intervene surgically. The objective of this review is to summarize the current literature regarding the criteria for surgical excision of mediastinal cysts and provide a framework for the clinician and surgeon to arrive at a decision regarding the appropriateness of surgical intervention of mediastinal cysts. Methods: A review of the published literature in the last 45 years (1977-2022) was conducted through PubMed, MeSh and Google Scholar. We included retrospective reviews, meta-analyses, and case studies published in the English language. A single author identified eligible studies, and those identified were reviewed by the team until consensus was met. Pediatric literature was excluded from this review. Key Content and Findings: The current literature predominantly contains case studies, small retrospective studies, and meta-analyses describing mediastinal cysts. In the anterior mediastinum, multiloculated thymic cysts should be resected to rule out thymic malignancy. Intralesional fat, smooth borders, and a more midline location are features suggestive of a benign process, while asymmetric cystic wall thickening has been associated with malignancy. Both esophageal and bronchogenic cysts should be excised, taking into account the risk of complications (up to a 45% risk) of infection, rupture, or compression, as well as the rare risk of associated malignancy. Simple thymic and small pericardial cysts can be observed and followed with serial radiographic tools and should be resected if they increase in size, compress surrounding structures, or lead the patient to develop symptoms. Conclusions: Since mediastinal cysts are rare and often asymptomatic, there are no formal guidelines outlining when surgical intervention should be undertaken. Based on our review of the literature, surgical intervention should be pursued if the patient's symptoms correlate with radiographic findings of a mediastinal cyst, there is compression of the surrounding structures, and concern of malignancy is present.

3.
4.
Ann Thorac Surg ; 114(3): e169-e172, 2022 09.
Article in English | MEDLINE | ID: mdl-34968446

ABSTRACT

Despite early clinical success of transcatheter pulmonic valve replacement, there is concern for an increased risk of endocarditis requiring complex surgery to repair. We present a case of endocarditis of a Melody (Medtronic, Minneapolis, MN) valve in a 33-year-old male patient with prior neonatal repair of persistent truncus arteriosus and 2 subsequent right ventricular outflow tract to pulmonary artery conduit replacements. The infection had extended from the Melody valve through the prior ventricular septal defect patch to the truncal valve and highlights the risk of endocarditis, particularly with the Melody transcatheter valve.


Subject(s)
Cardiac Surgical Procedures , Endocarditis , Heart Defects, Congenital , Heart Valve Prosthesis Implantation , Heart Valve Prosthesis , Pulmonary Valve , Adult , Cardiac Catheterization/adverse effects , Endocarditis/surgery , Heart Defects, Congenital/surgery , Heart Valve Prosthesis/adverse effects , Heart Valve Prosthesis Implantation/adverse effects , Humans , Infant, Newborn , Male , Pulmonary Valve/surgery , Treatment Outcome
5.
J Surg Educ ; 79(2): 516-523, 2022.
Article in English | MEDLINE | ID: mdl-34642097

ABSTRACT

OBJECTIVE: The objective of this study was to obtain the perception of patients on the use of portable digital media devices by providers during patient care and compare the findings to a previous study that examined providers' perceptions on the use of these devices. DESIGN: This was a cross-sectional survey study. SETTING: This study took place at a large tertiary referral center. PARTICIPANTS: Participants were identified via inpatient lists from general surgery services. RESULTS: Of those eligible to participate, 70% completed the questionnaire. While some situations were seen as less appropriate, the overall consensus from participants was that informing the patient of why the physician is using a digital media device made it more appropriate. CONCLUSION: Patients recognize digital device use in healthcare is appropriate and professional when discussed with them in advance. Overall, patients and providers are in agreement that portable digital technology can improve patient care and open communication about the use improves the provider-patient relationship. There is some risk to patient trust in using digital devices in their presence.


Subject(s)
Internet , Professionalism , Cross-Sectional Studies , Humans , Patient Care , Surveys and Questionnaires
6.
Bariatr Surg Pract Patient Care ; 17(4): 197-205, 2022 Dec 01.
Article in English | MEDLINE | ID: mdl-36636335

ABSTRACT

Background: Suboptimal weight loss (SWL) occurs up to 30% after sleeve gastrectomy (SG). Conversion to Roux-en-Y gastric bypass (cRYGB) has shown heterogeneous results in terms of additional weight loss and resolution of weight-related comorbidities. We aim to evaluate mid-term outcomes of cRYGB specifically for SWL after SG. Methods: All patients who underwent cRYGB for SWL from April 2010 to June 2019 from prospective registries at three affiliated tertiary care centers were retrospectively reviewed. Patients who underwent revision or conversion for complications were excluded. Mixed-effects and polynomial regression models were used to evaluate weight loss results after conversion. Results: Thirty-two patients underwent cRYGB from SG. About 68.7% were women with mean age of 46.6 years. Mean body mass index (BMI) before SG was 55.3 kg/m2. Before conversion, mean BMI was 44.5 kg/m2 with 17.3% total weight loss (TWL). All procedures were completed laparoscopically in a median surgical time of 183 min. Three major complications occurred (9.3%), one gastrojejunal (GJ) leak and two reoperations. Four cases (12.5%) of GJ stenosis were diagnosed. No mortality was registered. Mean follow-up time was 24 months and patients had 36 kg/m2 mean BMI, 17.4% TWL, 27.2% had BMI >35 kg/m2. Conclusions: cRYGB after SG for SWL showed good mid-term results, better than those reported in literature.

7.
J Thorac Cardiovasc Surg ; 161(3): 1080-1093.e4, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33436290

ABSTRACT

OBJECTIVE: Congenitally corrected transposition of the great arteries (ccTGA) encompasses a diverse morphologic cohort, for which multiple treatment pathways exist. Understanding surgical outcomes among various pathways and their determinants are challenged by limited sample size and follow-up, and heterogeneity. We sought to investigate these questions with a large cohort of ccTGA patients presenting at different ages and representing the full therapeutic spectrum. METHODS: Retrospective review of 240 patients diagnosed with ccTGA from Cleveland Clinic coupled with prospective cross-sectional follow-up. Forty-six patients whose definitive procedure was completed elsewhere were excluded. Time-related survival was described among treatment pathways using actuarial, time-varying covariate, and competing risks analyses. Temporal trends in longitudinal valve and ventricular function were assessed using nonlinear mixed-effects models. RESULTS: Median follow-up was 10 years. Seventy-nine patients with ccTGA underwent anatomic repair, 45 physiologic repair, 24 Fontan palliation, and 6 primary transplant. Forty patients managed expectantly had excellent long-term survival when considered from time of presentation, but benefited from failures captured following transition to physiologic repair or transplant. Morphologic right ventricular dysfunction after physiologic repair increased from 68% to 85% after 5 years, whereas morphologic left ventricular function was stable in anatomic repair, especially with early surgery. Transplant-free survival at 15 years for anatomic and physiologic repair was 80% and 71%, respectively. CONCLUSIONS: Early anatomic repair may be preferable to physiologic repair for select ccTGA patients. Late attrition after physiologic repair represents failure of expectant management and progressive tricuspid valve and morphologic right ventricular dysfunction compared with anatomic repair, where morphologic left ventricular function is relatively preserved.


Subject(s)
Cardiac Surgical Procedures , Congenitally Corrected Transposition of the Great Arteries/surgery , Critical Pathways , Adolescent , Adult , Aged , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/mortality , Child , Child, Preschool , Congenitally Corrected Transposition of the Great Arteries/diagnostic imaging , Congenitally Corrected Transposition of the Great Arteries/mortality , Congenitally Corrected Transposition of the Great Arteries/physiopathology , Cross-Sectional Studies , Female , Humans , Infant , Male , Middle Aged , Ohio , Postoperative Complications/etiology , Prospective Studies , Recovery of Function , Retrospective Studies , Risk Factors , Survivors , Time Factors , Time-to-Treatment , Treatment Outcome , Young Adult
8.
J Clin Rheumatol ; 27(6S): S294-S300, 2021 Sep 01.
Article in English | MEDLINE | ID: mdl-33252393

ABSTRACT

OBJECTIVES: Chronic musculoskeletal pain (CMP) causes significant health loss worldwide. Given that cultural factors may affect pain processing, it is key to have more information regarding CMP epidemiology in Latin America. In this study, we aimed to determine the prevalence of CMP and chronic widespread pain (CWP) in Chile. METHODS: This was a cross-sectional survey study. We used data recollected in the 2016-2017 Chilean National Health Survey, a nationwide household survey. Our study population included subjects older than 14 years living in urban and rural Chile. We defined CMP as nontraumatic pain with a duration of longer than 3 months. Chronic widespread pain was defined by the presence of CMP in 5 body regions. The association between CMP and CWP and potential risk factors was investigated through univariate and multivariate logistic regression models. RESULTS: After excluding subjects with missing information our final sample constituted 4045 subjects. Chronic musculoskeletal pain was present in 21.8% (95% confidence interval, 19.6%-24.1%) and CWP in 4.2% (95% confidence interval, 3.3%-5.1%). Significant risk factors in multivariate analysis were older age, female sex, lower educational level, and depressive symptoms. Factors associated with a reduced risk of CMP were not being married and moderate alcohol consumption. CONCLUSIONS: One of 5 Chilean people has chronic pain, and 1 of 20 has CWP. Data regarding alcohol and pain have been controversial in previous studies; therefore, this decreased risk in moderate consumers should be further explored. Chronic widespread pain shared risk factors and protective factors with CMP but with a higher magnitude of association.


Subject(s)
Chronic Pain , Musculoskeletal Pain , Aged , Chile/epidemiology , Chronic Pain/diagnosis , Chronic Pain/epidemiology , Cross-Sectional Studies , Female , Health Surveys , Humans , Musculoskeletal Pain/diagnosis , Musculoskeletal Pain/epidemiology , Prevalence
9.
Sci Rep ; 7(1): 9702, 2017 08 29.
Article in English | MEDLINE | ID: mdl-28851980

ABSTRACT

Cardiac progenitor cells (CPCs) have been shown to promote cardiac regeneration and improve heart function. However, evidence suggests that their regenerative capacity may be limited in conditions of severe hypoxia. Elucidating the mechanisms involved in CPC protection against hypoxic stress is essential to maximize their cardioprotective and therapeutic potential. We investigated the effects of hypoxic stress on CPCs and found significant reduction in proliferation and impairment of vasculogenesis, which were associated with induction of quiescence, as indicated by accumulation of cells in the G0-phase of the cell cycle and growth recovery when cells were returned to normoxia. Induction of quiescence was associated with a decrease in the expression of c-Myc through mechanisms involving protein degradation and upregulation of p21. Inhibition of c-Myc mimicked the effects of severe hypoxia on CPC proliferation, also triggering quiescence. Surprisingly, these effects did not involve changes in p21 expression, indicating that other hypoxia-activated factors may induce p21 in CPCs. Our results suggest that hypoxic stress compromises CPC function by inducing quiescence in part through downregulation of c-Myc. In addition, we found that c-Myc is required to preserve CPC growth, suggesting that modulation of pathways downstream of it may re-activate CPC regenerative potential under ischemic conditions.


Subject(s)
Cell Cycle , Hypoxia/metabolism , Myocytes, Cardiac/metabolism , Neovascularization, Physiologic , Proto-Oncogene Proteins c-myc/metabolism , Stress, Physiological , Animals , Cell Differentiation , Cell Proliferation , Cell Survival , Cellular Senescence , Gene Expression , Glycogen Synthase Kinase 3 beta/metabolism , Mice , Protein Stability , Proto-Oncogene Proteins c-myc/genetics
10.
J Womens Health (Larchmt) ; 26(8): 918-921, 2017 08.
Article in English | MEDLINE | ID: mdl-28686517

ABSTRACT

The clinical update serves as a brief review of recently published, high-impact, and potentially practice changing journal articles summarized for our readers. Topics include menopause, sexual dysfunction, breast health, contraception, osteoporosis, and cardiovascular disease. In this clinical update, we selected recent publications relevant to osteoporosis management. We highlight articles on the safety of long-term use of denosumab and bisphosphonates, fracture risk after discontinuing menopausal hormone therapy, calcium intake and cardiovascular risk, as well as the value of repeat dual X-ray absorptiometry scanning to monitor those on osteoporosis treatment.


Subject(s)
Bone Density Conservation Agents/therapeutic use , Denosumab/therapeutic use , Diphosphonates/therapeutic use , Osteoporosis/drug therapy , Practice Guidelines as Topic , Absorptiometry, Photon , Female , Hormone Replacement Therapy , Humans , Osteoporotic Fractures/prevention & control , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...